LOC-Organized Symposium

New Therapeutical Strategies

8:00 am- Thursday, Oct 20th
　Chair: Paul J Declerck and John Morser
LOCS-1--DS-1040, a novel inhibitor of the activated form of thrombin-activatable fibrinolysis inhibitor (TAFIa)
　Jin Zhou, Kengo Noguchi, Naoko Edo, Victor Dishy, Jarema Kochan, Ophelia Yin
LOCS-2--Selective PAI-1 Antagonists: Recent Advances and Novel Applications
　Douglas E. Vaughan, Toshio Miyata
LOCS-3--Plasminogen as a Novel Therapeutic Agent to Treat Non-Healing Wounds
　Tor E.R Ny, Mahsa Fallah, Malgorzata Wilczynska, Yue Shen, Rima Sulniute

Morning Seminar

Thrombomodulin; Physiological and Pharmacological Modulator of Haemostasis and Inflammation

8:00 pm- Friday, Oct 21st
　Chair: Koji Suzuki
MS-1--Thrombin-thrombomodulin system in the hemostatic system and its clinical implication
Ikuro Maruyama, Takashi Ito
MS-2--Anti-inflammatory and anticoagulant roles of thrombomodulin in sepsis-associated DIC
Takashi Ito, Ikuro Maruyama

Evening Seminar

Protein S and Thrombophilia

4:30 pm- Wednesday, Oct 19th
　Chair: Masahiro Ieko
ES--Protein S-specific activity as an indicator of thrombophilia
Naotaka Hamasaki
Commentator: Takao Kobayashi